Log in

Ovid Therapeutics Insider Trades (NASDAQ:OVID)

-0.05 (-1.20 %)
(As of 12/13/2019 02:33 AM ET)
Today's Range
Now: $4.10
50-Day Range
MA: $3.03
52-Week Range
Now: $4.10
Volume573,400 shs
Average Volume479,446 shs
Market Capitalization$196.05 million
P/E RatioN/A
Dividend YieldN/A

Insider Trades

Ovid Therapeutics (NASDAQ:OVID) Insider Buying and Selling Activity

Insider Ownership Percentage: 29.80%

Insider Buying and Selling by Quarter

Ovid Therapeutics (NASDAQ OVID) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/8/2019Jeremy M LevinCEOBuy60,000$2.13$127,800.00
10/8/2019Pharmaceutical Co Ltd TakedaMajor ShareholderBuy2,000,000$2.50$5,000,000.00  
2/26/2019Karen BernsteinDirectorBuy10,000$2.02$20,200.00  
2/22/2019Jeremy M LevinCEOBuy75,000$2.00$150,000.00  
8/14/2018Douglas E WilliamsDirectorBuy5,000$6.49$32,450.00  
8/25/2017Jeremy M LevinCEOBuy15,334$7.15$109,638.104,601,529  
(Data available from 1/1/2013 forward)
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel